Quantum Biopharma Ltd. (QNTM) Cash from Discontinued Operations (2019 - 2022)

Quantum Biopharma (QNTM) has 6 years of Cash from Discontinued Operations data on file, last reported at 9459251.0 in Q4 2024.

• Quarterly Cash from Discontinued Operations rose 42.94% year-over-year to 9459251.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 20891746.0 (down 12.56% YoY) and the FY2022 annual result came in at 1142982.0, up 17.3% from the prior year.
• Cash from Discontinued Operations retreated to 9459251.0 in Q4 2024 per QNTM's latest filing, from 4015327.0 in the prior quarter.
• The five-year high for Cash from Discontinued Operations was 4015327.0 in Q3 2024, with the low at 16579022.0 in Q4 2023.
• Average Cash from Discontinued Operations over 5 years is 1940599.15, with a median of 18870.95 recorded in 2020.
• Year-over-year, Cash from Discontinued Operations tumbled 194.75% in 2020 and surged 930.31% in 2021.
• Quantum Biopharma's Cash from Discontinued Operations stood at 43193.64 in 2020, then plunged by 6139.17% to 2608536.0 in 2021, then soared by 80.67% to 504264.0 in 2022, then plunged by 3187.77% to 16579022.0 in 2023, then surged by 42.94% to 9459251.0 in 2024.
• Business Quant data shows QNTM's Cash from Discontinued Operations at 9459251.0 in Q4 2024, 4015327.0 in Q3 2024, and 16579022.0 in Q4 2023.